1. Check if you qualify
Take our quick and easy quiz to see if Eversense 365 could work for you. We’ll check your diabetes therapy and insurance to see if you qualify.
Simplify Your Eversense CGM Prescription with Expert Guidance
There are just three easy steps between you and the world's first and only ONE YEAR CGM.
Three easy steps. One brief office visit per year.
2. Connect with an Eversense Expert
An Expert will get in touch to answer your questions, navigate insurance, and coordinate with an Eversense Inserter near you.
3. Sensor placement
One sensor placement is all you need for a year. A trained healthcare provider places the sensor, with only a small incision - usually involving no stitches and only a bandage!
WATCH OUR VIDEO ABOUT THE PLACEMENTWhat to expect at the sensor placement appointment
Wondering how the Eversense 365 sensor gets in your arm? Click to see how simple the sensor placement is.
See why people are choosing
Eversense 365.
Learn more about the experiences of Eversense users whose lives were changed after switching to a long-term CGM.
Want to see if you
qualify?
Take our quick and easy quiz to see if Eversense 365 could work for you.
The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For important safety information, see bit.ly/eversensesafety
Eversense, Eversense E3 Continuous Glucose Monitoring, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.
PP-SENS-E3-GBL-0047